Results 101 to 110 of about 64,504 (248)
ESC Heart Failure, EarlyView.Abstract Aims Hypertrophic cardiomyopathy (HCM) is an inherited cardiomyopathy often caused by pathogenic variants in MYBPC3 and MYH7, encoding myosin‐binding protein C3 and myosin heavy chain 7, respectively. These variants can cause increased actin–myosin crossbridge cycling, resulting in ventricular hypercontractility, but mice lacking Mybpc3 ...
Isabell Yan +10 more
wiley +1 more source
Severe aortic stenosis without left ventricular hypertrophy: prevalence, predictors, and short-term follow up after aortic valve replacement. [PDF]
, 1996 Christian Seiler, Rolf Jenni
openalex +1 more source
Aortic stenosis intricacies beyond the valve: A bidirectional Mendelian randomization study
ESC Heart Failure, EarlyView.Abstract Aims Numerous observational studies have reported an association between calcific aortic valve stenosis (CAVS) and an increased risk of other cardiovascular diseases (CVDs). However, the potential causal association is uncertain. Methods and results A bidirectional Mendelian randomization (MR) analysis was performed to confirm the causal ...
Dihui Cai, Jianhui Liu
wiley +1 more source
Aortic valve replacement with a pulmonary autograft in infants with critical aortic stenosis [PDF]
, 1996 Göran Südow +5 more
openalex +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 1514-1522, April 2025.
Takamasa Iwai +4 more
wiley +1 more source
ESC Heart Failure, EarlyView.Abstract Aims This study evaluated the prognostic value of the relative apical sparing pattern (RASP) of longitudinal strain (LS) in patients with severe aortic stenosis (AS) undergoing transcatheter aortic valve replacement (TAVR) and investigated whether its combination with pre‐procedural biomarkers enhances risk stratification.
Dan Liu +8 more
wiley +1 more source
First Report of Evolut Pro+ Transcatheter Aortic Valve-in-Valve in a Degenerated Lotus Valve
Structural HeartThe increasing use of transcatheter aortic valves in patients with aortic stenosis has led to a higher number of valve-in-valve procedures due to gradual valve degeneration. We present a case of a 72-year-old woman who received transcatheter aortic valve
Thorald Stolte, BSc +3 more
doaj +1 more source
Clinical impact of tricuspid regurgitation in patients with acute myocardial infarction
ESC Heart Failure, EarlyView.Abstract Aims The clinical impact of tricuspid regurgitation (TR) in patients after acute myocardial infarction (AMI) is largely unknown. The aim of this study was to clarify the prevalence and prognostic impact of TR in post‐AMI patients treated with appropriate primary percutaneous coronary intervention (PCI).
Shun Nishino +5 more
wiley +1 more source
ESC Heart Failure, EarlyView.Abstract Background and aims The pulmonary artery pulsatility index (PAPi), that is, the pulmonary artery pulse pressure (PAPP) divided by the mean right atrial pressure (mRAP), is an increasingly used invasive index of right ventricular function. We sought to assess the prognostic impact of the PAPi in unselected patients with aortic stenosis (AS ...
Laura A. Rechsteiner +9 more
wiley +1 more source